U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine - Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSYGKPNE5ZPRXH2OTG23T4DSYI.jpg)
6/3/2022 12:00:00 AM2 years 11 months ago
The U.S. Food and Drug Administration hasraised concerns about a possible risk of heart inflammation from Novavax Inc's <a href="https://www.reuters.com/companies/NVAX.O" target="_blank">(NVAX.O)</a>COVID-19 vaccine, even as the company's data showed it could…
June 3 (Reuters) - The U.S. Food and Drug Administration hasraised concerns about a possible risk of heart inflammation from Novavax Inc's (NVAX.O)COVID-19 vaccine, even as the company's data showed … [+2828 chars]
full article...